Ombitasvir, Paritaprevir, and Ritonavir and Trastuzumab and Hyaluronidase
Determining the interaction of Ombitasvir, Paritaprevir, and Ritonavir and Trastuzumab and Hyaluronidase and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ombitasvir / paritaprevir / ritonavir
Brand name: Technivie
Synonyms: n.a.
Generic Name: hyaluronidase / trastuzumab
Brand name: Herceptin Hylecta
Synonyms: Hyaluronidase and trastuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ombitasvir, Paritaprevir, and Ritonavir-Trastuzumab Injection (Intravenous)
- Ombitasvir, Paritaprevir, and Ritonavir-Trastuzumab Intravenous
- Ombitasvir, Paritaprevir, and Ritonavir-Trastuzumab-anns
- Ombitasvir, Paritaprevir, and Ritonavir-Trastuzumab-dkst
- Ombitasvir, Paritaprevir, and Ritonavir-Trastuzumab-dkst Intravenous
- Ombitasvir, Paritaprevir, and Ritonavir-Trasylol
- Trastuzumab and Hyaluronidase-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Trastuzumab and Hyaluronidase-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Trastuzumab and Hyaluronidase-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Trastuzumab and Hyaluronidase-Omeclamox-Pak
- Trastuzumab and Hyaluronidase-Omega-3 Fatty Acid Capsules
- Trastuzumab and Hyaluronidase-Omega-3 Fatty Acids